BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Intestine
,
Early pregnancy factor
,
Quercetin
,
rs2230926
,
IL1A
,
Obesity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Cdc2
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Atrioventricular node
Heart
Heart ventricle
Coronary artery
Vena cava
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Triple negative breast cancer CAL51 cells treated with Cdc2-like kinase 2 (CLK2) inhibitor CC-671
Type 2 conventional dendritic cells (cDC2s) CD1C+ of primary Sjogren's sicca & non-Sjogren's sicca
Conventional dendritic cell (CD1c+) subsets differing in CD5 expression
S.pombe gene expression profiles of wildtype and tra1 mutants
Bone marrow pre-mucosal and retinoic acid (RA) derived CD103+CD11b+/CD11b- dendritic cells (DCs)
Explore Curated Studies Results
Literature
Most Relevant Literature
Therapeutic potential of CDK11 in cancer.
CDK11 facilitates centromeric transcription to maintain centromeric cohesion during mitosis.
CDK11 requires a critical activator SAP30BP to regulate pre-mRNA splicing.
Crystal structure of the CDK11 kinase domain bound to the small-molecule inhibitor OTS964.
CDK11 regulates pre-mRNA splicing by phosphorylation of SF3B1.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Erlotinib in Treating Patients With Barrett Esophagus
Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Mal…
A Phase 0 Study of AZD1775 in Recurrent GBM Patients
AZD1775 for Advanced Solid Tumors
A Dose Escalation Study of MK-1775 in Combination With Either Gemcitabine, Cisplatin, or Carboplatin…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ